PASG
Price:
$0.7831
Market Cap:
$48.37M
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD-GRN; and PBKR03, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also d...[Read more]
Industry
Biotechnology
IPO Date
2020-02-28
Stock Exchange
NASDAQ
Ticker
PASG
According to Passage Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 41.90M. This represents a change of -23.70% compared to the average of 54.91M of the last 4 quarters.
The mean historical Enterprise Value of Passage Bio, Inc. over the last ten years is 425.77M. The current 41.90M Enterprise Value has changed 884.00% with respect to the historical average. Over the past ten years (40 quarters), PASG's Enterprise Value was at its highest in in the December 2020 quarter at 1.03B. The Enterprise Value was at its lowest in in the March 2020 quarter at -89249826.75.
Average
425.77M
Median
358.44M
Minimum
59.88M
Maximum
857.85M
Discovering the peaks and valleys of Passage Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 69.16%
Maximum Annual Enterprise Value = 857.85M
Minimum Annual Increase = -75.39%
Minimum Annual Enterprise Value = 59.88M
Year | Enterprise Value | Change |
---|---|---|
2023 | 59.88M | -11.45% |
2022 | 67.62M | -67.77% |
2021 | 209.77M | -75.39% |
2020 | 852.41M | -0.63% |
2019 | 857.85M | 69.16% |
The current Enterprise Value of Passage Bio, Inc. (PASG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
112.42M
5-year avg
409.50M
10-year avg
425.77M
Passage Bio, Inc.’s Enterprise Value is less than Black Diamond Therapeutics, Inc. (141.04M), less than Revolution Medicines, Inc. (8.08B), greater than Homology Medicines, Inc. (-103303255.00), less than Stoke Therapeutics, Inc. (504.84M), greater than Cabaletta Bio, Inc. (-11685032.00),
Company | Enterprise Value | Market cap |
---|---|---|
141.04M | $141.46M | |
8.08B | $8.19B | |
-103303255.00 | $3.02M | |
504.84M | $652.55M | |
-11685032.00 | $143.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Passage Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Passage Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Passage Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Passage Bio, Inc. (PASG)?
What is the 3-year average Enterprise Value for Passage Bio, Inc. (PASG)?
What is the 5-year average Enterprise Value for Passage Bio, Inc. (PASG)?
How does the current Enterprise Value for Passage Bio, Inc. (PASG) compare to its historical average?